NCT06291363View on ClinicalTrials.gov

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

PHASE4RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

March 3, 2025

Study Completion Date

March 4, 2025

Conditions
Opioid Use, UnspecifiedAnesthesiaNociceptive Pain
Interventions
DRUG

Esmolol Hydrochloride

Patients in the experimental group will receive esmolol during general anesthesia

DRUG

Saline

Patients in the standard of care group will receive saline as placebo during general anesthesia

Trial Locations (1)

H1T2M4

RECRUITING

Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal, Montreal East

All Listed Sponsors
lead

Ciusss de L'Est de l'Île de Montréal

OTHER